Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-18T10:06:24.662Z Has data issue: false hasContentIssue false

GUANFACINE

Published online by Cambridge University Press:  03 May 2024

Stephen M. Stahl
Affiliation:
University of California, San Diego
Jeffrey R. Strawn
Affiliation:
University of Cincinnati, Ohio
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Prescriber's Guide – Children and Adolescents
Stahl's Essential Psychopharmacology
, pp. 279 - 286
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Black, BT, Soden, SE, Kearns, GL, Jones, BL. Clinical and pharmacologic considerations for guanfacine use in very young children. J Child Adolesc Psychopharmacol 2016;26(6):498504.CrossRefGoogle ScholarPubMed
Boellner, SW, Pennick, M, Fiske, K, Lyne, A, Shojaei, A. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Pharmacotherapy 2007;27(9):1253–62.CrossRefGoogle ScholarPubMed
Catalá-López, F, Hutton, B, Nuñez-Beltrán, A et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One. 2017;12(7):e0180355.CrossRefGoogle ScholarPubMed
Connor, DF, Grasso, DJ, Slivinsky, MD, et al. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol 2013; 23:244.CrossRefGoogle ScholarPubMed
Kemper, AR, Maslow, GR, Hill, S et al. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents. Comparative Effectiveness Review No. 203. AHRQ Publication No. 18-EHC005-EF. Rockville, MD: Agency for Healthcare Research and Quality; January 2018.Google ScholarPubMed
Pliszka, S ; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46(7):894921.CrossRefGoogle ScholarPubMed
Ruggiero, S, Clavenna, , Reale, L et al. Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis. Eur Neuropsychopharmacol 2014;24(10):1589–90.CrossRefGoogle Scholar
Sallee, FR, McGough, J, Wigal, T et al.; SPD503 STUDY GROUP. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2009;48(2):155–65.CrossRefGoogle ScholarPubMed
Sayer, GR, McGough, JJ, Levitt, J et al. Acute and long-term cardiovascular effects of stimulant, guanfacine, and combination therapy for attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2016;26(10):882–8.CrossRefGoogle ScholarPubMed
Strawn, JR, Compton, SN, Robertson, B et al. Extended release guanfacine in pediatric anxiety disorders: a pilot, randomized, placebo-controlled trial. J Child Adolesc Psychopharmacol 2017;27(1):2937.CrossRefGoogle ScholarPubMed
Strawn, JR, Keeshin, BR, Cohen, JA. Posttraumatic stress disorder in children and adolescents: treatment and overview. UpToDate 2023. Last updated Sept. 6, 2023.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • GUANFACINE
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.031
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • GUANFACINE
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.031
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • GUANFACINE
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.031
Available formats
×